Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Rhapsody Venture Partners is a venture capital firm based in the United States, focusing on seed-stage investments in hard science startups. They screen around 2,000 startups annually, with a team dedicated to supporting scientific founders in commercializing innovative technologies. Their investment strategy emphasizes early partnerships with industry leaders to enhance market fit and expedite commercialization.
The firm invests between $500,000 and $2 million in seed-stage startups across sectors such as biotech, healthcare, industrial, energy, agtech, and AI. Rhapsody prioritizes companies that demonstrate potential in agriculture, manufacturing, and electronics, often leading larger syndicates in follow-on rounds to support growth.
Rhapsody Venture Partners has backed notable companies including Chinova, which creates natural formulations to protect food products; HyperDamping, known for innovative damping materials; Adden, developing advanced solid-state batteries; and Biophilica, producing a plastic-free leather alternative. Other investments include Fluid Efficiency, SpinDrive, Cnergreen, Wavelogix, NuCicer, Netpreme, and NODAR.
Submit your pitch through their form at rhapsodyvp.com.
Yes, Rhapsody often leads larger syndicates in follow-on rounds, providing additional support to their portfolio companies.
Rhapsody Venture Partners is open to leading follow-on investments, ensuring continued support for startups that demonstrate growth potential.
Specific details about the size of Rhapsody's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.